Annual EBITDA
$2.04 B
-$2.32 B-53.21%
31 December 2023
Summary:
Biogen annual earnings before interest, taxes, depreciation & amortization is currently $2.04 billion, with the most recent change of -$2.32 billion (-53.21%) on 31 December 2023. During the last 3 years, it has fallen by -$3.70 billion (-64.45%). BIIB annual EBITDA is now -73.88% below its all-time high of $7.80 billion, reached on 31 December 2019.BIIB EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
$626.70 M
-$292.20 M-31.80%
30 September 2024
Summary:
Biogen quarterly earnings before interest, taxes, depreciation & amortization is currently $626.70 million, with the most recent change of -$292.20 million (-31.80%) on 30 September 2024. Over the past year, it has increased by +$579.10 million (+1216.60%). BIIB quarterly EBITDA is now -71.72% below its all-time high of $2.22 billion, reached on 30 June 2020.BIIB Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
$2.73 B
+$579.10 M+26.92%
30 September 2024
Summary:
Biogen TTM earnings before interest, taxes, depreciation & amortization is currently $2.73 billion, with the most recent change of +$579.10 million (+26.92%) on 30 September 2024. Over the past year, it has increased by +$361.40 million (+15.26%). BIIB TTM EBITDA is now -66.19% below its all-time high of $8.08 billion, reached on 30 June 2020.BIIB TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BIIB EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -53.2% | +1216.6% | +15.3% |
| 3 y3 years | -64.5% | +27.7% | -9.8% |
| 5 y5 years | -70.2% | -70.9% | -65.1% |
BIIB EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -64.5% | at low | -59.6% | +1216.6% | -38.9% | +33.9% |
| 5 y | 5 years | -73.9% | at low | -71.7% | +1216.6% | -66.2% | +33.9% |
| alltime | all time | -73.9% | +353.5% | -71.7% | +161.8% | -66.2% | +423.1% |
Biogen EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $626.70 M(-31.8%) | $2.73 B(+26.9%) |
| June 2024 | - | $918.90 M(+34.8%) | $2.15 B(+2.1%) |
| Mar 2024 | - | $681.50 M(+35.4%) | $2.11 B(+3.4%) |
| Dec 2023 | $2.04 B(-53.2%) | $503.20 M(+957.1%) | $2.04 B(-13.9%) |
| Sept 2023 | - | $47.60 M(-94.6%) | $2.37 B(-38.8%) |
| June 2023 | - | $874.60 M(+42.7%) | $3.87 B(-13.3%) |
| Mar 2023 | - | $613.10 M(-26.5%) | $4.47 B(+1.3%) |
| Dec 2022 | $4.36 B(+51.3%) | $833.60 M(-46.3%) | $4.41 B(+5.4%) |
| Sept 2022 | - | $1.55 B(+5.6%) | $4.18 B(+34.0%) |
| June 2022 | - | $1.47 B(+164.1%) | $3.12 B(+7.9%) |
| Mar 2022 | - | $556.60 M(-8.2%) | $2.90 B(-2.6%) |
| Dec 2021 | $2.88 B(-49.8%) | $606.00 M(+23.5%) | $2.97 B(-1.7%) |
| Sept 2021 | - | $490.60 M(-60.5%) | $3.03 B(-17.4%) |
| June 2021 | - | $1.24 B(+95.9%) | $3.66 B(-21.0%) |
| Mar 2021 | - | $634.30 M(-3.6%) | $4.64 B(-21.0%) |
| Dec 2020 | $5.73 B(-26.5%) | $658.10 M(-41.7%) | $5.87 B(-16.8%) |
| Sept 2020 | - | $1.13 B(-49.1%) | $7.05 B(-12.7%) |
| June 2020 | - | $2.22 B(+18.9%) | $8.08 B(+3.8%) |
| Mar 2020 | - | $1.86 B(+1.2%) | $7.78 B(-2.1%) |
| Dec 2019 | $7.80 B(+14.0%) | $1.84 B(-14.5%) | $7.95 B(+1.6%) |
| Sept 2019 | - | $2.15 B(+12.0%) | $7.82 B(-0.7%) |
| June 2019 | - | $1.92 B(-5.2%) | $7.88 B(+7.1%) |
| Mar 2019 | - | $2.03 B(+18.1%) | $7.36 B(+4.5%) |
| Dec 2018 | $6.85 B(+6.0%) | $1.72 B(-22.2%) | $7.04 B(+0.7%) |
| Sept 2018 | - | $2.21 B(+57.5%) | $6.99 B(+5.4%) |
| June 2018 | - | $1.40 B(-18.2%) | $6.63 B(+0.4%) |
| Mar 2018 | - | $1.71 B(+2.5%) | $6.61 B(+2.3%) |
| Dec 2017 | $6.46 B(+10.0%) | $1.67 B(-9.6%) | $6.46 B(+10.1%) |
| Sept 2017 | - | $1.85 B(+34.1%) | $5.87 B(+4.2%) |
| June 2017 | - | $1.38 B(-11.7%) | $5.63 B(-4.5%) |
| Mar 2017 | - | $1.56 B(+44.6%) | $5.90 B(+0.4%) |
| Dec 2016 | $5.88 B(+7.6%) | $1.08 B(-33.0%) | $5.88 B(-3.8%) |
| Sept 2016 | - | $1.61 B(-1.8%) | $6.10 B(+1.5%) |
| June 2016 | - | $1.64 B(+6.8%) | $6.01 B(+4.7%) |
| Mar 2016 | - | $1.54 B(+17.5%) | $5.74 B(+5.1%) |
| Dec 2015 | $5.46 B(+17.1%) | $1.31 B(-14.1%) | $5.46 B(-0.1%) |
| Sept 2015 | - | $1.52 B(+11.0%) | $5.47 B(+3.9%) |
| June 2015 | - | $1.37 B(+9.2%) | $5.27 B(+4.1%) |
| Mar 2015 | - | $1.26 B(-4.4%) | $5.06 B(+8.4%) |
| Dec 2014 | $4.66 B(+53.2%) | $1.32 B(-0.2%) | $4.66 B(+12.0%) |
| Sept 2014 | - | $1.32 B(+13.2%) | $4.17 B(+13.2%) |
| June 2014 | - | $1.16 B(+34.8%) | $3.68 B(+11.4%) |
| Mar 2014 | - | $864.31 M(+5.8%) | $3.30 B(+8.5%) |
| Dec 2013 | $3.04 B(+34.9%) | $817.28 M(-2.0%) | $3.04 B(+10.0%) |
| Sept 2013 | - | $833.97 M(+5.9%) | $2.77 B(+7.8%) |
| June 2013 | - | $787.83 M(+30.2%) | $2.57 B(+7.6%) |
| Mar 2013 | - | $605.02 M(+11.7%) | $2.39 B(+5.7%) |
| Dec 2012 | $2.26 B(+7.3%) | $541.49 M(-14.5%) | $2.26 B(+1.8%) |
| Sept 2012 | - | $633.61 M(+4.5%) | $2.22 B(+2.7%) |
| June 2012 | - | $606.30 M(+27.4%) | $2.16 B(+5.3%) |
| Mar 2012 | - | $475.86 M(-5.1%) | $2.05 B(-6.2%) |
| Dec 2011 | $2.10 B(+29.7%) | $501.35 M(-13.0%) | $2.19 B(+2.1%) |
| Sept 2011 | - | $576.03 M(+15.7%) | $2.14 B(+15.6%) |
| June 2011 | - | $497.79 M(-18.5%) | $1.85 B(+0.2%) |
| Mar 2011 | - | $610.78 M(+34.0%) | $1.85 B(+13.9%) |
| Dec 2010 | $1.62 B(-9.7%) | $455.68 M(+59.0%) | $1.62 B(-2.1%) |
| Sept 2010 | - | $286.66 M(-41.9%) | $1.66 B(-10.8%) |
| June 2010 | - | $493.34 M(+27.8%) | $1.86 B(+6.9%) |
| Mar 2010 | - | $386.11 M(-21.4%) | $1.74 B(-3.2%) |
| Dec 2009 | $1.80 B(+7.6%) | $491.14 M(+0.7%) | $1.80 B(+3.6%) |
| Sept 2009 | - | $487.92 M(+30.6%) | $1.73 B(+1.8%) |
| June 2009 | - | $373.63 M(-15.8%) | $1.70 B(-2.2%) |
| Mar 2009 | - | $443.85 M(+3.6%) | $1.74 B(+4.3%) |
| Dec 2008 | $1.67 B(+25.4%) | $428.30 M(-6.4%) | $1.67 B(-0.6%) |
| Sept 2008 | - | $457.81 M(+11.1%) | $1.68 B(+12.5%) |
| June 2008 | - | $412.22 M(+10.9%) | $1.49 B(+5.7%) |
| Mar 2008 | - | $371.72 M(-15.1%) | $1.41 B(+5.9%) |
| Dec 2007 | $1.33 B(+53.2%) | $437.80 M(+61.6%) | $1.33 B(+14.5%) |
| Sept 2007 | - | $270.89 M(-18.5%) | $1.16 B(-3.2%) |
| June 2007 | - | $332.39 M(+13.6%) | $1.20 B(+42.0%) |
| Mar 2007 | - | $292.61 M(+8.9%) | $847.03 M(-2.6%) |
| Dec 2006 | $868.93 M(+30.1%) | $268.69 M(-13.2%) | $869.59 M(+8.3%) |
| Sept 2006 | - | $309.48 M(-1403.1%) | $802.88 M(+26.2%) |
| June 2006 | - | -$23.75 M(-107.5%) | $636.08 M(-21.8%) |
| Mar 2006 | - | $315.18 M(+56.0%) | $813.86 M(+21.8%) |
| Dec 2005 | $668.05 M(+27.9%) | $201.98 M(+41.6%) | $668.05 M(+3.9%) |
| Sept 2005 | - | $142.68 M(-7.4%) | $643.21 M(-8.4%) |
| June 2005 | - | $154.02 M(-9.1%) | $702.41 M(+6.7%) |
| Mar 2005 | - | $169.37 M(-4.4%) | $658.34 M(+26.0%) |
| Dec 2004 | $522.43 M | $177.14 M(-12.3%) | $522.42 M(-178.0%) |
| Sept 2004 | - | $201.88 M(+83.6%) | -$669.48 M(-15.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2004 | - | $109.95 M(+228.6%) | -$789.47 M(-6.6%) |
| Mar 2004 | - | $33.46 M(-103.3%) | -$845.16 M(+5.1%) |
| Dec 2003 | -$804.13 M(-412.0%) | -$1.01 B(-1339.1%) | -$804.13 M(-429.8%) |
| Sept 2003 | - | $81.89 M(+50.9%) | $243.84 M(+0.8%) |
| June 2003 | - | $54.26 M(-27.1%) | $241.85 M(-10.7%) |
| Mar 2003 | - | $74.48 M(+124.3%) | $270.71 M(-9.7%) |
| Dec 2002 | $257.75 M(-40.1%) | $33.21 M(-58.4%) | $299.84 M(-25.4%) |
| Sept 2002 | - | $79.91 M(-3.9%) | $401.76 M(-12.2%) |
| June 2002 | - | $83.11 M(-19.8%) | $457.63 M(-3.6%) |
| Mar 2002 | - | $103.61 M(-23.3%) | $474.62 M(+1.8%) |
| Dec 2001 | $430.47 M(-18.8%) | $135.13 M(-0.5%) | $466.36 M(-22.8%) |
| Sept 2001 | - | $135.77 M(+35.6%) | $604.18 M(+12.2%) |
| June 2001 | - | $100.11 M(+5.0%) | $538.46 M(+0.9%) |
| Mar 2001 | - | $95.35 M(-65.1%) | $533.53 M(+0.6%) |
| Dec 2000 | $530.45 M(+52.7%) | $272.95 M(+289.7%) | $530.45 M(+30.4%) |
| Sept 2000 | - | $70.05 M(-26.4%) | $406.85 M(-5.0%) |
| June 2000 | - | $95.19 M(+3.2%) | $428.30 M(+2.9%) |
| Mar 2000 | - | $92.27 M(-38.2%) | $416.05 M(+6.1%) |
| Dec 1999 | $347.35 M(+61.4%) | $149.35 M(+63.2%) | $392.30 M(+11.9%) |
| Sept 1999 | - | $91.50 M(+10.3%) | $350.48 M(+11.5%) |
| June 1999 | - | $82.93 M(+21.0%) | $314.28 M(+12.9%) |
| Mar 1999 | - | $68.52 M(-36.3%) | $278.35 M(+10.4%) |
| Dec 1998 | $215.23 M(+27.9%) | $107.53 M(+94.4%) | $252.03 M(+2.5%) |
| Sept 1998 | - | $55.30 M(+17.7%) | $245.96 M(+10.0%) |
| June 1998 | - | $47.00 M(+11.4%) | $223.66 M(+6.7%) |
| Mar 1998 | - | $42.20 M(-58.4%) | $209.56 M(+7.1%) |
| Dec 1997 | $168.26 M(+200.0%) | $101.46 M(+207.5%) | $195.66 M(+34.6%) |
| Sept 1997 | - | $33.00 M(+0.3%) | $145.39 M(-4.9%) |
| June 1997 | - | $32.90 M(+16.3%) | $152.89 M(+37.5%) |
| Mar 1997 | - | $28.30 M(-44.7%) | $111.19 M(+41.7%) |
| Dec 1996 | $56.09 M(+205.5%) | $51.19 M(+26.4%) | $78.49 M(+30.9%) |
| Sept 1996 | - | $40.50 M(-560.2%) | $59.96 M(+206.5%) |
| June 1996 | - | -$8.80 M(+100.0%) | $19.56 M(-29.0%) |
| Mar 1996 | - | -$4.40 M(-113.5%) | $27.56 M(-17.4%) |
| Dec 1995 | $18.36 M(+198.6%) | $32.66 M(>+9900.0%) | $33.36 M(+35.3%) |
| Sept 1995 | - | $100.00 K(-112.5%) | $24.65 M(+5389.8%) |
| June 1995 | - | -$800.00 K(-157.1%) | $449.00 K(-980.4%) |
| Mar 1995 | - | $1.40 M(-94.2%) | -$51.00 K(-100.5%) |
| Dec 1994 | $6.15 M(-78.3%) | $23.95 M(-199.4%) | $9.75 M(-151.6%) |
| Sept 1994 | - | -$24.10 M(+1753.8%) | -$18.90 M(-227.7%) |
| June 1994 | - | -$1.30 M(-111.6%) | $14.80 M(-45.0%) |
| Mar 1994 | - | $11.20 M(-338.3%) | $26.90 M(0.0%) |
| Dec 1993 | $28.40 M(-20.4%) | -$4.70 M(-149.0%) | $26.90 M(-53.9%) |
| Sept 1993 | - | $9.60 M(-11.1%) | $58.40 M(-1.0%) |
| June 1993 | - | $10.80 M(-3.6%) | $59.00 M(+25.8%) |
| Mar 1993 | - | $11.20 M(-58.2%) | $46.90 M(+33.2%) |
| Dec 1992 | $35.70 M(+839.5%) | $26.80 M(+162.7%) | $35.20 M(+319.0%) |
| Sept 1992 | - | $10.20 M(-884.6%) | $8.40 M(-660.0%) |
| June 1992 | - | -$1.30 M(+160.0%) | -$1.50 M(-225.0%) |
| Mar 1992 | - | -$500.00 K(<-9900.0%) | $1.20 M(-69.2%) |
| Dec 1991 | $3.80 M(-17.4%) | $0.00(-100.0%) | $3.90 M(-39.1%) |
| Sept 1991 | - | $300.00 K(-78.6%) | $6.40 M(-5.9%) |
| June 1991 | - | $1.40 M(-36.4%) | $6.80 M(+23.6%) |
| Mar 1991 | - | $2.20 M(-12.0%) | $5.50 M(+25.0%) |
| Dec 1990 | $4.60 M(-180.7%) | $2.50 M(+257.1%) | $4.40 M(-1566.7%) |
| Sept 1990 | - | $700.00 K(+600.0%) | -$300.00 K(-90.3%) |
| June 1990 | - | $100.00 K(-90.9%) | -$3.10 M(-183.8%) |
| Mar 1990 | - | $1.10 M(-150.0%) | $3.70 M(-65.4%) |
| Dec 1989 | -$5.70 M(-35.2%) | -$2.20 M(+4.8%) | $10.70 M(-176.4%) |
| Sept 1989 | - | -$2.10 M(-130.4%) | -$14.00 M(+68.7%) |
| June 1989 | - | $6.90 M(-14.8%) | -$8.30 M(-11.7%) |
| Mar 1989 | - | $8.10 M(-130.1%) | -$9.40 M(-21.0%) |
| Dec 1988 | -$8.80 M(-56.9%) | -$26.90 M(-847.2%) | -$11.90 M(-25.6%) |
| Sept 1988 | - | $3.60 M(-37.9%) | -$16.00 M(-10.1%) |
| June 1988 | - | $5.80 M(+3.6%) | -$17.80 M(-18.7%) |
| Mar 1988 | - | $5.60 M(-118.1%) | -$21.90 M(-9.9%) |
| Dec 1987 | -$20.40 M(-18.4%) | -$31.00 M(-1822.2%) | -$24.30 M(-13.2%) |
| Sept 1987 | - | $1.80 M(+5.9%) | -$28.00 M(-3.8%) |
| June 1987 | - | $1.70 M(-46.9%) | -$29.10 M(+1.0%) |
| Mar 1987 | - | $3.20 M(-109.2%) | -$28.80 M(-1.4%) |
| Dec 1986 | -$25.00 M(-12.0%) | -$34.70 M(-5057.1%) | -$29.20 M(-26.3%) |
| Sept 1986 | - | $700.00 K(-65.0%) | -$39.60 M(+9.1%) |
| June 1986 | - | $2.00 M(-28.6%) | -$36.30 M(+9.3%) |
| Mar 1986 | - | $2.80 M(-106.2%) | -$33.20 M(+0.6%) |
| Dec 1985 | -$28.40 M(+77.5%) | -$45.10 M(-1227.5%) | -$33.00 M(+38.1%) |
| Sept 1985 | - | $4.00 M(-21.6%) | -$23.90 M(+8.6%) |
| June 1985 | - | $5.10 M(+70.0%) | -$22.00 M(+2.8%) |
| Mar 1985 | - | $3.00 M(-108.3%) | -$21.40 M(+5.9%) |
| Dec 1984 | -$16.00 M | -$36.00 M(-710.2%) | -$20.20 M(-227.8%) |
| Sept 1984 | - | $5.90 M(+3.5%) | $15.80 M(+59.6%) |
| June 1984 | - | $5.70 M(+35.7%) | $9.90 M(+135.7%) |
| Mar 1984 | - | $4.20 M | $4.20 M |
FAQ
- What is Biogen annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Biogen?
- What is Biogen annual EBITDA year-on-year change?
- What is Biogen quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Biogen?
- What is Biogen quarterly EBITDA year-on-year change?
- What is Biogen TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Biogen?
- What is Biogen TTM EBITDA year-on-year change?
What is Biogen annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of BIIB is $2.04 B
What is the all time high annual EBITDA for Biogen?
Biogen all-time high annual earnings before interest, taxes, depreciation & amortization is $7.80 B
What is Biogen annual EBITDA year-on-year change?
Over the past year, BIIB annual earnings before interest, taxes, depreciation & amortization has changed by -$2.32 B (-53.21%)
What is Biogen quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of BIIB is $626.70 M
What is the all time high quarterly EBITDA for Biogen?
Biogen all-time high quarterly earnings before interest, taxes, depreciation & amortization is $2.22 B
What is Biogen quarterly EBITDA year-on-year change?
Over the past year, BIIB quarterly earnings before interest, taxes, depreciation & amortization has changed by +$579.10 M (+1216.60%)
What is Biogen TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of BIIB is $2.73 B
What is the all time high TTM EBITDA for Biogen?
Biogen all-time high TTM earnings before interest, taxes, depreciation & amortization is $8.08 B
What is Biogen TTM EBITDA year-on-year change?
Over the past year, BIIB TTM earnings before interest, taxes, depreciation & amortization has changed by +$361.40 M (+15.26%)